TAT-SNAP-23 (University of Louisville)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameTAT-SNAP-23 (University of Louisville)
Drug Alias NameTAT fusion protein (University of Louisville)TAT-SNAP-23
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionHuman Immunodeficiency Virus tat Gene Products modulators
TargetsHuman Immunodeficiency Virus tat Gene Products
Therapy Area/IndicationsInflammationAcute Lung Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Louisville
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Louisville
Active IndicationsN/A
Inactive IndicationsInflammationAcute Lung Injury

Other Information

ATC CodeN/A
Related LinksN/A